We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICER Backpedals on Cost-Effectiveness of Rheumatoid Arthritis Treatments
ICER Backpedals on Cost-Effectiveness of Rheumatoid Arthritis Treatments
In an usual move, the Institute for Clinical and Economic Review (ICER) quickly withdrew a draft report that questioned the cost-effectiveness of three rheumatoid arthritis treatments, saying that it needs to reconsider its approach.